Fiche centre
CHU de Tours
Tours — France
Essais liés4clinical trials
VilleTourslocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT01521988
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Atrial flutter ablation | Maladie coronarienne | Non applicable | NCT01521988 | PAF CRIOBLAF — Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation | COMPLETED |
| Obinutuzumab | Cancer | Phase 2 | NCT06806033 | A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma | RECRUITING |
| deferiprone | Sclérose latérale amyotrophique | Phase 2/3 | NCT03293069 | FAIR-ALS II — Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis | COMPLETED |
| FG-CoALS — French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis | Sclérose latérale amyotrophique | Non applicable | NCT06147843 | FG-CoALS — French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis | RECRUITING |